• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Caprius to add three joint ventures

Article

Breast MRI developer Caprius has received three letters of intent for joint ventures utilizing the Wilmington, MA-based company’s Aurora scanner, which is the only dedicated MRI breast imaging system to have received Food and Drug Administration

Breast MRI developer Caprius has received three letters of intent for joint ventures utilizing the Wilmington, MA-based company’s Aurora scanner, which is the only dedicated MRI breast imaging system to have received Food and Drug Administration 510(k) clearance. The joint ventures’ partners would be located in New York City, Columbus, OH, and Knoxville, TN, and would be similar to other joint ventures currently in operation in sites such as Magee Women’s Hospital and Englewood Hospital and Medical Center, according to Caprius.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.